Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome

NCT02098993 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment.

Conditions

Acute Chest Syndrome
Sickle Cell Disease

Interventions

DRUG: Unfractionated heparin

Sponsor

Craig Seaman

Collaborators

[object Object]